« Previous
Next »
Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 2
, Pages 120-127
, June 2007
Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers
References
- A new class of polymers: starburst dendrimeric macromolecules. J. Polym. 1985;17:117–132
- . Poly(propylene imine) dendrimers: large scale synthesis by heterogeneously catalyzed hydrogenation. Angew Chem Int Ed Engl. 1993;32:1308–1311
- . Unimolecular micelles and globular amphiphiles: dendrimeric macromolecules as novel recyclable solubilization agents. J Chem Soc Perkin Trans. 1993;1:1287–1297
- . Water soluble unimolecular micelles: their potential as drug delivery agents. J Control Rel. 2000;65:121–131
- . Synthesis, characterization, and guest host properties of inverted unimolecular dendrimeric micelles. J Am Chem Soc. 1996;118:7398–7399
- . Supramolecules with novel properties: metallodendrimers. Chem Rev. 1999;99:1689–1746
- . Synthesis, cellular transport, and activity of polyamidoamine dendrimers-methyl prednisolone conjugates. Bioconjugate Chem. 2005;16:330–337
- . Doxorubicin-PAMAM dendrimers complex attached to liposomes: cytotoxic studies against human cancer cell lines. Int J Pharm. 2005;302:29–38
- . Drug complexation in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int J Pharm. 2003;259:143–160
- . Synthesis of polyamidoamine dendrimers having poly(ethylene) glycol grafts and their ability to encapsulate anticancer drugs. Bioconjugate Chem. 2000;11:910–917
- . Dendrimeric micelles for controlled drug release and targeted delivery. Mol Pharm. 2005;2:264–272
- . Preparation, cellular transport and activity of polyamidoamine-based dendrimeric nanodevices with a high drug payload. Biomaterials. 2005;27:660–669
- . Synthesis, cellular transport and activity of polyamidoamine dendrimer-methylprednisolone conjugates. Bioconjugate Chem. 2005;16:330–337
- . Dendrimers: a new class of nanoscopic containers and delivery devices. Eur Polym J. 2003;39:1741–1771
- . In vitro and in vivo gene transfer by optimized (-cyclodextrin conjugate with polyamido amine dendrimer. Bioconjugate Chem. 2003;14:342–350
- . The lower-generation polypropyleneimine dendrimers are effective gene transfer agents. Pharm Res. 2002;19:960–967[judy]
- . Synthetic carbohydrate containing dendrimers. Chem Eur J. 1997;38:1193–1199
- . Solid phase synthesis of dendrimeric sialoside inhibitors of influenza A virus hemaglutinin. J Chem Soc Commun. 1993;24:1869–1872
- Dendrimers: relationship between structure and biocompatibility in vitro and preliminary studies on the biodistribution of 125I-labeled polyamidoamine dendrimers in vivo. J Control Rel. 2000;65:133–148
- . Preliminary biological evaluations of polyamidoamine (PAMAM) starburst dendrimers. J Biomed Res. 1996;30:53–65
- . Biotin reagents for antibody pretargeting, 3. Synthesis, radioiodination, and evaluation of biotinylated starburst dendrimers. Bioconjugate Chem. 1998;9:813–825
- Synthesis of glycodendrimers by modification of poly(propylene imine) dendrimers. Chem Eur J. 1997;3:974–984
- . Influence of administration route on tumour uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumour bearing mice. J Control Rel. 2005;105:185–198
- . Enhanced tumour uptake of doxorubicin loaded poly(butyl cynoacrylate) nanoparticles in mice bearing Dalton's lymphoma tumours. J Drug Target. 2004;2:443–451
- . Efficiency of chitosan microspheres for controlled intra-articular delivery of celecoxib in inflamed joints. J Pharm Pharmcol. 2004;56:1091–1099
- . Etoposide incorporated tripalmitin nanoparticles with different surface charge: formation, characterization, radiolabeling and biodistribution studies. AAPS J. 2004;6:1–10
- . Labeling efficiency and biodistribution of technetium-99m labeled nanoparticles: influence by colloidal tin particles. Int J Pharm. 2005;289:189–195
- . Design, functional evaluation and biomedical application of carbohydrate dendrimers (glycodendrimers). Rev Mol Biotechnol. 2000;90:269–290
- . Drug delivery systems based on sugar-macromolecule conjugates. Curr Opin Drug Discovery Dev. 2002;5:279–288
- . Liposomal drug delivery systems-clinical applications. Acta Pharm. 2005;55:1–25
- . Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther. 2006;5:1909–1917
- . Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers. J Drug Target. 2006;14:546–556
- . Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. Int J Pharm. 2005;295:221–233
- . Distribution and tissue uptake of poly(ethylene) glycol with different molecular weights after intravenous administration to mice. J Pharm Sci. 1994;83:601–606
- . Soluble synthetic polymers in biological systems. Adv Polym Sci. 1984;57:23–49
- . Galactose specific receptors on liver cells II. Characterization of purified receptors from macrophages reveals no structural relationship to hepatocyte receptors. Biochim Biophys Acta. 1985;847:115–121
- . Kupffer cells. In: Arias IM, Jakavy WB, Popper H, Schacter D, Shafritz DA editor. The liver: biology and pathobiology. 2nd ed.. New York: Raven; 1988;p. 683–704
- . Scavenger properties of cultivated pig liver endothelial cell. Comp Hepatol. 2004;3:1–11
- . Biochemistry of carbohydrate-protein interaction. FASEB J. 1992;6:3193–3200
- . Cell specific ligands for drug delivery to tissues and organs. J Med Chem. 1981;24:1388–1395
- . Versatile synthesis of bi- and tri-antenary galactose ligands: interactions with Gal/GalNac receptors of human hepatoma cells. Glycoconj J. 1995;12:275–281
- . One-pot synthesis of antigen bearing, leucine base cluster mannoside using two orthogonal chemoselective ligation interactions. Angew Chem Int Ed. 2000;39:1068–1072
- . Studies on the kinetics of uptake and distribution of free and liposome entrapped primaquine and of sporozoites by isolated perfused rat liver. Ann Trop Med Parasitol. 1983;77:379–386
- . Selective liver targeting of antiviral by recombinant chylomicrons-a new therapecutic approach to hepatitis B. Nat Med. 1995;1:221–225
No conflict of interest was reported by the authors of this paper.
PII: S1549-9634(07)00048-2
doi: 10.1016/j.nano.2007.02.002
© 2007 Elsevier Inc. All rights reserved.
« Previous
Next »
Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 2
, Pages 120-127
, June 2007
